Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 4 days ago

      After dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...

    • Letter: We need alternatives to opioids

      Letter: We need alternatives to opioids

      Bangor Daily News· 1 day ago

      As a retired millworker, I have witnessed the devastating impact of the opioid crisis on mill towns throughout Maine and communities around the entire...

    • Medicare Glossary

      US News Health· 6 days ago

      Don't let Medicare terminology surprise you. Consider Bev, a 66-year-old retiree who opted out of Medicare Parts C and D due to good health and minimal care needs. Although many vaccines are ...

    • Gateway - Quartz

      Quartz· 4 days ago

      Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...